1. Articles from biospace.com

  2. 1-24 of 81 1 2 3 4 »
    1. Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano

      Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano

      DURHAM, N.C., March 11, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences Inc. (Nasdaq: DTIL), a life sciences company dedicated to improving life through the application of its pioneering, proprietary ARCUS® genome editing platform, announced today that Geno Germano, President and CEO of Elucida Oncology, has been appointed to the company’s Board of Directors...

      Read Full Article
    2. Axial Biotherapeutics Strengthens and Expands Board of Directors and Leadership Team

      Axial Biotherapeutics Strengthens and Expands Board of Directors and Leadership Team

      WALTHAM, Mass.--(BUSINESS WIRE)-- Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced the appointment of Scott Brun M.D. to its Board of Directors...

      Read Full Article
    3. BeyondSpring Appoints Pharma Veterans Drs. Daniel Zabrowski and Ramon Mohanlal to Company’s Board of Directors

      BeyondSpring Appoints Pharma Veterans Drs. Daniel Zabrowski and Ramon Mohanlal to Company’s Board of Directors

      NEW YORK, Jan. 23, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced the appointments of Drs. Daniel Zabrowski and Ramon Mohanlal to the Company’s Board of Directors...

       

      Read Full Article
    4. Foghorn® Therapeutics Appoints Scott Biller, Ph.D., to Board of Directors

      Foghorn® Therapeutics Appoints Scott Biller, Ph.D., to Board of Directors

      CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foghorn® Therapeutics Inc. (Foghorn), a company advancing an entirely new class of medicines targeting diseases with genetically determined dependencies in the chromatin regulatory system, today appointed Scott Biller, Ph.D., to its Board of Directors...

      Read Full Article
    5. Kezar Life Sciences Enhances Clinical Expertise with the Appointment of Elizabeth Garner, MD, MPH to its Board of Directors

      Kezar Life Sciences Enhances Clinical Expertise with the Appointment of Elizabeth Garner, MD, MPH to its Board of Directors

      SOUTH SAN FRANCISCO, Calif., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Kezar Life SciencesInc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmune disease and cancer, today announced the appointment of Elizabeth Garner, MD, MPH to its Board of Directors. Dr. Garner is currently the Chief Medical Officer of ObsEva SA...

      Read Full Article
    6. IDEAYA Biosciences Appoints Wendy Yarno to its Board of Directors

      IDEAYA Biosciences Appoints Wendy Yarno to its Board of Directors

      SOUTH SAN FRANCISCO, Calif., Dec. 18, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced the appointment of Wendy L. Yarno as a Director of its Board of Directors...

      Read Full Article
    7. Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors

      Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors

      RADNOR, Pa., Dec. 12, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marinus” or “Company”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy, depression and other neuropsychiatric disorders, announced today that Elan Ezickson, has joined the Company’s Board of Directors...

      Read Full Article
    8. ChanceLight Behavioral Health, Therapy and Education Names John McLaughlin, Ph.D., to Board of Directors

      ChanceLight Behavioral Health, Therapy and Education Names John McLaughlin, Ph.D., to Board of Directors

      NASHVILLE, Tenn.Sept. 12, 2019 /PRNewswire/ -- ChanceLight Behavioral Health, Therapy and Education, the nation's leading provider of behavioral health, therapy and education solutions for children and young adults, today announced John McLaughlin, Ph.D., has transitioned from ChanceLight Executive Vice President to a member of the Board of Directors...

      Read Full Article
    1-24 of 81 1 2 3 4 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content